NanoFCM U30 Dual Laser Flow NanoAnalyzer

The Food and Drug Administration is seeking to acquire a NanoFCM U30 Dual Laser Flow NanoAnalyzer to enhance its capabilities in nanoparticle assessment. This equipment will be utilized by FDA researchers for the characterization of extracellular vesicles, synthetic nanoparticles, and viral vectors. The acquisition aims to address current limitations on the FDA campus regarding throughput and the lack of multiparametric analysis tools, adopting a technology that is widely recognized as a standard in extracellular vesicle research. This procurement is categorized as a forecast under NAICS code 334516. While a specific contracting officer has not yet been named, the program point of contact is the CBER Acquisition Liaison. The instrument will provide critical single nanoparticle analysis capabilities that are currently unavailable within the agency's existing infrastructure.